181 related articles for article (PubMed ID: 26351271)
41. MethCNA: a database for integrating genomic and epigenomic data in human cancer.
Deng G; Yang J; Zhang Q; Xiao ZX; Cai H
BMC Genomics; 2018 Feb; 19(1):138. PubMed ID: 29433427
[TBL] [Abstract][Full Text] [Related]
42. Predicting censored survival data based on the interactions between meta-dimensional omics data in breast cancer.
Kim D; Li R; Dudek SM; Ritchie MD
J Biomed Inform; 2015 Aug; 56():220-8. PubMed ID: 26048077
[TBL] [Abstract][Full Text] [Related]
43. Computational approaches for the identification of cancer genes and pathways.
Dimitrakopoulos CM; Beerenwinkel N
Wiley Interdiscip Rev Syst Biol Med; 2017 Jan; 9(1):. PubMed ID: 27863091
[TBL] [Abstract][Full Text] [Related]
44. Fuse: multiple network alignment via data fusion.
Gligorijević V; Malod-Dognin N; Pržulj N
Bioinformatics; 2016 Apr; 32(8):1195-203. PubMed ID: 26668003
[TBL] [Abstract][Full Text] [Related]
45. Molecular characterization of breast cancer cell lines through multiple omic approaches.
Smith SE; Mellor P; Ward AK; Kendall S; McDonald M; Vizeacoumar FS; Vizeacoumar FJ; Napper S; Anderson DH
Breast Cancer Res; 2017 Jun; 19(1):65. PubMed ID: 28583138
[TBL] [Abstract][Full Text] [Related]
46. Gene expression trends and protein features effectively complement each other in gene function prediction.
Wabnik K; Hvidsten TR; Kedzierska A; Van Leene J; De Jaeger G; Beemster GT; Komorowski J; Kuiper MT
Bioinformatics; 2009 Feb; 25(3):322-30. PubMed ID: 19050035
[TBL] [Abstract][Full Text] [Related]
47. Computational identification of multi-omic correlates of anticancer therapeutic response.
Stetson LC; Pearl T; Chen Y; Barnholtz-Sloan JS
BMC Genomics; 2014; 15 Suppl 7(Suppl 7):S2. PubMed ID: 25573145
[TBL] [Abstract][Full Text] [Related]
48. JFCR39, a panel of 39 human cancer cell lines, and its application in the discovery and development of anticancer drugs.
Kong D; Yamori T
Bioorg Med Chem; 2012 Mar; 20(6):1947-51. PubMed ID: 22336246
[TBL] [Abstract][Full Text] [Related]
49. Indole carboxylic acid esters of melampomagnolide B are potent anticancer agents against both hematological and solid tumor cells.
Bommagani S; Ponder J; Penthala NR; Janganati V; Jordan CT; Borrelli MJ; Crooks PA
Eur J Med Chem; 2017 Aug; 136():393-405. PubMed ID: 28525840
[TBL] [Abstract][Full Text] [Related]
50. Prediction of protein-RNA binding sites by a random forest method with combined features.
Liu ZP; Wu LY; Wang Y; Zhang XS; Chen L
Bioinformatics; 2010 Jul; 26(13):1616-22. PubMed ID: 20483814
[TBL] [Abstract][Full Text] [Related]
51. The Flint Animal Cancer Center (FACC) Canine Tumour Cell Line Panel: a resource for veterinary drug discovery, comparative oncology and translational medicine.
Fowles JS; Dailey DD; Gustafson DL; Thamm DH; Duval DL
Vet Comp Oncol; 2017 Jun; 15(2):481-492. PubMed ID: 27197945
[TBL] [Abstract][Full Text] [Related]
52. Systematic assessment of multi-gene predictors of pan-cancer cell line sensitivity to drugs exploiting gene expression data.
Nguyen L; Dang CC; Ballester PJ
F1000Res; 2016; 5():. PubMed ID: 28299173
[No Abstract] [Full Text] [Related]
53. Analysis of pathway activity in primary tumors and NCI60 cell lines using gene expression profiling data.
Feng XD; Huang SG; Shou JY; Liao BR; Yingling JM; Ye X; Lin X; Gelbert LM; Su EW; Onyia JE; Li SY
Genomics Proteomics Bioinformatics; 2007 Feb; 5(1):15-24. PubMed ID: 17572360
[TBL] [Abstract][Full Text] [Related]
54. Evaluating the molecule-based prediction of clinical drug responses in cancer.
Ding Z; Zu S; Gu J
Bioinformatics; 2016 Oct; 32(19):2891-5. PubMed ID: 27354694
[TBL] [Abstract][Full Text] [Related]
55. HTS384 NCI60: The Next Phase of the NCI60 Screen.
Kunkel MW; Coussens NP; Morris J; Taylor RC; Dexheimer TS; Jones EM; Doroshow JH; Teicher BA
Cancer Res; 2024 Jun; ():. PubMed ID: 38861359
[TBL] [Abstract][Full Text] [Related]
56. Large inherent variability in data derived from highly standardised cell culture experiments.
Reddin IG; Fenton TR; Wass MN; Michaelis M
Pharmacol Res; 2023 Feb; 188():106671. PubMed ID: 36681368
[TBL] [Abstract][Full Text] [Related]
57. Analysis of impedance-based cellular growth assays.
Witzel F; Fritsche-Guenther R; Lehmann N; Sieber A; Blüthgen N
Bioinformatics; 2015 Aug; 31(16):2705-12. PubMed ID: 25900918
[TBL] [Abstract][Full Text] [Related]
58. Exposure time independent summary statistics for assessment of drug dependent cell line growth inhibition.
Falgreen S; Laursen MB; Bødker JS; Kjeldsen MK; Schmitz A; Nyegaard M; Johnsen HE; Dybkær K; Bøgsted M
BMC Bioinformatics; 2014 Jun; 15():168. PubMed ID: 24902483
[TBL] [Abstract][Full Text] [Related]
59. Gene expression associations with the growth inhibitory effects of small molecules on live cells: specificity of effects and uniformity of mechanisms.
Shedden K; Yang Y; Rosania G
Stat Anal Data Min; 2009 Sep; 2(3):175-185. PubMed ID: 20657799
[TBL] [Abstract][Full Text] [Related]
60. Addendum: The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.
Barretina J; Caponigro G; Stransky N; Venkatesan K; Margolin AA; Kim S; Wilson CJ; Lehár J; Kryukov GV; Sonkin D; Reddy A; Liu M; Murray L; Berger MF; Monahan JE; Morais P; Meltzer J; Korejwa A; Jané-Valbuena J; Mapa FA; Thibault J; Bric-Furlong E; Raman P; Shipway A; Engels IH; Cheng J; Yu GK; Yu J; Aspesi P; de Silva M; Jagtap K; Jones MD; Wang L; Hatton C; Palescandolo E; Gupta S; Mahan S; Sougnez C; Onofrio RC; Liefeld T; MacConaill L; Winckler W; Reich M; Li N; Mesirov JP; Gabriel SB; Getz G; Ardlie K; Chan V; Myer VE; Weber BL; Porter J; Warmuth M; Finan P; Harris JL; Meyerson M; Golub TR; Morrissey MP; Sellers WR; Schlegel R; Garraway LA
Nature; 2019 Jan; 565(7738):E5-E6. PubMed ID: 30559381
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
